Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Preconference

Preconference Concluding Remarks

Sunday, November 10, 2024
4:30 PM – 4:45 PM MST
Location: Sonoran Sky Ballroom 4

    Speaker(s)

  • Joy C. Hsu, PhD

    Director, Clinical Pharmacology and Pharmacometrics
    Genentech
    South San Francisco, California, United States

    Disclosure(s): Roche: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

  • Mark Lovern, PhD (he/him/his)

    Chief Platform Officer
    InSilicoTrials
    RALEIGH, North Carolina, United States

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Joy C. Hsu, PhD: Roche: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Mark Lovern, PhD: No financial relationships to disclose